American International Group, Inc. (AIG): what the price requires
At today's price, American International Group, Inc. (AIG) is priced for 9.9% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/AIG
Headline
| Field | Value |
|---|---|
| Ticker | AIG |
| Company | American International Group, Inc. |
| Current price | $79.94/sh |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | financials |
| Return on equity needed | 9.9% |
| Return on equity now | 7.5% |
| ROE gap | +2.4pp |
| Price-to-book | 1.05x |
Solve inputs: computed at a 9.6% cost of equity with 4% terminal growth over a 5-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~1.1pp.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | +0.59σ |
| cohort percentile (of 80 peers) | 16 |
| sustained it ~10 years at this level | 76% |
| implied end-window share | 0% |
Valuation X-Ray
The price is supported by earnings-power and relative-multiple value, while growth-DCF lands below the price. A value/asset-supported name, not a pure growth bet.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.27x | 3 | expensive |
| Earnings | 0.87x | 2 | justifies |
| Relative | 0.40x | 3 | justifies |
| Growth | 1.68x | 1 | expensive |
Families that justify the price: Earnings, Relative Families that call it expensive: Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 3.5%); the inversion above states its own rate.
Per-Model Detail (n=9)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | — | — | no | — |
| Bank Fair Value (P/TBV) | — | $45.32 | 1.76x | yes | TBVPS $68.22 × 0.66x (ROE (TTM) 7.8% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption)) |
| Relative Valuation | Relative | $62.48 | 1.28x | yes | P/E 11x (static sector reference · 2026-04), scenarios: 9.3x / 11.0x / 12.7x (bear / base = reference held flat / bull), EV/EBITDA 10x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $63.03 | 1.27x | yes | BV/sh $74.53, ROE (TTM) 7.8%, ke 9.3% |
| Two-Stage Excess Return | Asset | $57.85 | 1.38x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $47.49 | 1.68x | yes | Rev $26.6B, growth -2% (input: historical growth; tapered), Terminal P/S: 1.4x / 1.6x / 1.9x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $198.80 | 0.40x | yes | EPS $5.68, growth 35% (input: historical EPS growth), PEG=0.39 (Undervalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | $97.59 | 0.82x | yes | √(22.5 × EPS $5.68 × BVPS $74.53) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | — | — | no | — |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $183.27 | 0.44x | yes | EPS $5.68 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | — | — | no | — |
| PEG Fair Value | Relative | $213.00 | 0.38x | yes | EPS $5.68 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $61.41 | 1.30x | yes | EPS $5.68 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Share count CAGR (buyback) | -10.0% |
Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).
Bullet Takeaways
An insurer is worth the return it earns on its capital. At $74.02 (June 27, 2026) AIG trades near one times book value, and the price assumes the company sustains a return on equity of about 9.5 percent, above the roughly 7.5 percent it has been earning.
The first quarter of 2026 showed the underwriting turn: the combined ratio improved to 89.4 percent from 107.9 percent, and after-tax operating income rose to $2.11 per diluted share from $1.17.
Management is shrinking the share count aggressively, returning $760 million in the quarter through buybacks and dividends, while the exit from Corebridge leaves a more focused property-and-casualty insurer.
Bull Case
The right lens for AIG is the one the market uses for any insurer: the company is worth the return it earns on its capital, read off price-to-book rather than an operating multiple. On that lens AIG looks reasonable. The stock trades near one times book value, and the price embeds a sustained return on equity of about 9.5 percent. The company has recently earned closer to 7.5 percent, so the bull case is simply that AIG closes most of that gap, a smaller ask than it sounds because the underwriting is already improving. The filing frames the discipline directly: management aims for "an acceptable risk-adjusted return on equity" and stays "disciplined in risk selection, premium adequacy, and appropriate terms and conditions to cover the risk accepted" (FY2025 10-K, accession 0000005272-26-000023).
The first quarter of 2026 is the evidence that the discipline is paying. The general insurance combined ratio improved to 89.4 percent from 107.9 percent a year earlier, an improvement of about 1,850 basis points, helped by lower catastrophe charges and favorable prior-year development, and the accident-year combined ratio improved 570 basis points on a better business mix and underwriting actions. A combined ratio under 90 means the core underwriting is profitable before investment income, which is exactly the engine an insurer needs to lift its return on equity. After-tax operating income rose to $1.1 billion, or $2.11 per diluted share, from $702 million, or $1.17, a near doubling.
The capital story compounds the underwriting story. AIG returned $760 million to shareholders in the quarter through roughly $519 million of buybacks, about 7 million shares, plus $241 million of dividends, and the share count has been shrinking at a double-digit annual rate. Buying back stock near book value mechanically lifts per-share book and return on equity. The exit from Corebridge, with AIG's stake reduced to about 5.6 percent after selling shares for roughly $750 million, completes the transformation into a focused property-and-casualty insurer, freeing capital and simplifying the story. An insurer trading around book, with a sub-90 combined ratio, a doubling of operating earnings, and a heavy buyback, is a value-and-asset-supported name where the return simply needs to hold.
Bear Case
The valuation methods do not agree, and the disagreement is the warning. The asset, earnings-power and peer-multiple frames support the price near book value, but the forward-growth method reads the stock as expensive. That split says the bull case is paying for a level of sustained return the static frames do not yet see in the numbers. The price assumes a return on equity of about 9.5 percent, while the company has recently earned about 7.5 percent. The gap is the entire bet, and a 9.5 percent return is right around AIG's roughly 9.7 percent cost of equity, so the market is paying book value for a company that, on its recent record, is not yet clearly earning its cost of capital. If the return settles back toward the 7.5 percent it has actually delivered rather than the 9.5 percent the price assumes, the stock is not cheap, it is fairly priced for a sub-cost-of-capital insurer.
The quarter that drove the optimism leaned on items that do not repeat on command. The combined-ratio improvement to 89.4 percent was helped by lower catastrophe charges and favorable prior-year reserve development, both of which can reverse. The filing is explicit that reserving "for unpaid losses and loss adjustment expenses is a complex process, particularly for long-tail and medium-tail liability lines of business," and that "there is also greater uncertainty in establishing reserves" for those lines (FY2025 10-K, accession 0000005272-26-000023). Favorable development this year can become adverse development next year, and a heavy catastrophe season would push the combined ratio back above the profitable line, undoing the return-on-equity improvement the price now assumes.
The history sets a sober base rate. Even granting that the assumed 9.5 percent return is within reach of what AIG has earned, only about 78 percent of firms earning a return at this level sustained it over a long horizon, and AIG sits in the lower half of its peer group on price-to-book for a reason: the market has watched this company promise an underwriting turn before. The buyback is value-accretive only while the stock stays near or below book and the return holds; if the return fades, repurchasing shares does not rescue the thesis. The model disagreement is really a question of which AIG is the real one, the 7.5 percent earner of the recent record or the 9.5 percent earner the price assumes, and the answer is not yet settled.
Valuation
An insurer is valued on the return it earns on its capital, so the price is read off price-to-book rather than an operating multiple. AIG trades near 0.97 times book value, and the price implies the company sustains a return on equity of about 9.5 percent against a roughly 9.7 percent cost of equity, with a 4 percent terminal growth assumption over a five-year stage. The asset, earnings-power and relative-multiple frames support the price at this level; only the forward-growth DCF reads it as expensive, and the blended central value across methods sits near $63.
The pivot is the return-on-equity gap. AIG has recently earned about 7.5 percent, and the price assumes about 9.5 percent, so the question is whether the underwriting improvement is durable enough to lift the return by roughly two points and hold it. The first quarter of 2026 supports the case, with the combined ratio at 89.4 percent and operating earnings per share of $2.11, but a single quarter aided by light catastrophes and favorable reserve development is not proof of a sustained 9.5 percent return. The valuation is broadly within range, neither demanding nor a bargain: paying about book value for a company that needs to earn near its cost of capital is fair if the return holds and slightly rich if it slips back. The buyback at around book value is the lever that helps the math, since repurchasing below or near book lifts per-share book and return on equity, and the Corebridge exit simplifies the capital picture. The reward depends on the underwriting turn proving structural rather than cyclical; the risk is that the assumed return is the better-than-average outcome, not the central one.
Catalysts
The combined ratio is the central catalyst because it drives the return on equity the price is paying for. The first quarter of 2026 combined ratio of 89.4 percent, down from 107.9 percent, and the accident-year combined ratio improving 570 basis points, are the trend to watch. Each quarter is a check on whether underwriting stays profitable before catastrophe and reserve noise, and on whether favorable prior-year development continues or reverses.
Capital return is the second catalyst. AIG returned $760 million in the quarter through roughly $519 million of buybacks and $241 million of dividends, and the pace of repurchases near book value is a direct lever on per-share book and return on equity. Watch the buyback authorization and execution, and any dividend changes, since the capital-return cadence is central to the per-share math.
The Corebridge exit and catastrophe exposure are the swing factors. With AIG's stake in Corebridge reduced to about 5.6 percent after roughly $750 million of share sales, the company is now a focused property-and-casualty insurer, and how it deploys the freed capital matters. The main external risk is the catastrophe season, since a heavy quarter of losses would push the combined ratio back above the profitable line and undercut the return-on-equity improvement. Quarterly results remain the main proof point on whether the underwriting turn is holding.
Peer Cohorts (Per Segment, With Filing Citations)
North America Commercial (reported)
- CB (Chubb Limited)
- (no filing in the citation store)
- TRV (Travelers Companies, Inc.)
- (no filing in the citation store)
- CNA (CNA FINANCIAL CORP)
- (no filing in the citation store)
- WRB (W. R. BERKLEY CORP)
- (no filing in the citation store)
- HIG (The Hartford Insurance Group, Inc.)
- (no filing in the citation store)
- ACGL (Arch Capital Group Ltd.)
- (no filing in the citation store)
- MKL (MARKEL GROUP INC.)
- (no filing in the citation store)
International Commercial (reported)
- CB (Chubb Limited)
- (no filing in the citation store)
- ACGL (Arch Capital Group Ltd.)
- (no filing in the citation store)
- AXS (AXIS CAPITAL HOLDINGS LIMITED)
- (no filing in the citation store)
- RNR (RENAISSANCERE HOLDINGS LTD)
- (no filing in the citation store)
- MKL (MARKEL GROUP INC.)
- (no filing in the citation store)
- WRB (W. R. BERKLEY CORP)
- (no filing in the citation store)
- RLI (RLI Corp)
- (no filing in the citation store)
Global Personal (reported)
- PGR (PROGRESSIVE CORP/OH/)
- (no filing in the citation store)
- ALL (ALLSTATE CORP)
- (no filing in the citation store)
- TRV (Travelers Companies, Inc.)
- (no filing in the citation store)
- CB (Chubb Limited)
- (no filing in the citation store)
- KMPR (Kemper Corporation)
- (no filing in the citation store)
- MCY (MERCURY GENERAL CORP)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.